share_log

ContraFect Has Received A Notice Of Allowance For Its U.S. Patent Application 16/629,916 Titled "Blood Component Potentiation Of Lytic Protein Anti-bacterial Activity And Methods And Uses Thereof"

ContraFect Has Received A Notice Of Allowance For Its U.S. Patent Application 16/629,916 Titled "Blood Component Potentiation Of Lytic Protein Anti-bacterial Activity And Methods And Uses Thereof"

ContraFect 已收到允許其美國專利申請 16/629,916 的通知,標題爲 “血液成分增強溶解蛋白抗菌活性及其方法和用途”
Benzinga ·  2023/10/24 11:08

ContraFect Has Received A Notice Of Allowance For Its U.S. Patent Application 16/629,916 Titled "Blood Component Potentiation Of Lytic Protein Anti-bacterial Activity And Methods And Uses Thereof"

ContraFect 已收到允許其美國專利申請 16/629,916 的通知,標題爲 “血液成分增強溶解蛋白抗菌活性及其方法和用途”

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論